ArticleMetabolic brain disease2021
Chronic administration of Tat-GluR23Y ameliorates cognitive dysfunction targeting CREB signaling in rats with amyloid beta neurotoxicity.
Fatemeh Ashourpour et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it